Cite
HARVARD Citation
Savasta, S. et al. (2017). Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination. Neurology. 7 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Savasta, S. et al. (2017). Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination. Neurology. 7 (6), p. . [Online].